153 related articles for article (PubMed ID: 11568556)
1. Motility-related proteins as markers for head and neck squamous cell cancer.
Abraham MT; Kuriakose MA; Sacks PG; Yee H; Chiriboga L; Bearer EL; Delacure MD
Laryngoscope; 2001 Jul; 111(7):1285-9. PubMed ID: 11568556
[TBL] [Abstract][Full Text] [Related]
2. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
4. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
6. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma.
de Oliveira MV; Pereira Gomes EP; Pereira CS; de Souza LR; Barros LO; Mendes DC; Guimarães AL; De Paula AM
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):444-51. PubMed ID: 23343952
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
11. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
16. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
[TBL] [Abstract][Full Text] [Related]
17. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
18. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
[TBL] [Abstract][Full Text] [Related]
19. Potential biomarkers for head and neck squamous cell carcinoma.
Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C contributes to head and neck squamous cell carcinoma growth and motility.
Benke EM; Ji Y; Patel V; Wang H; Miyazaki H; Yeudall WA
Oral Oncol; 2010 Apr; 46(4):e19-24. PubMed ID: 20227330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
